A selective increase in circulating inhibin and inhibin pro-alphaC at the time of ovulation in the mare. 1999

K Nagaoka, and Y Nambo, and N Nagamine, and S I Nagata, and Y Tanaka, and H Shinbo, and N Tsunoda, and H Taniyama, and G Watanabe, and N P Groome, and K Taya
Laboratory of Veterinary Physiology, Tokyo University of Agriculture and Technology, Tokyo 183-8509, Japan.

The relationship between a selective increase in circulating immunoreactive (ir)-inhibin and the time of ovulation was investigated in mares. Concentrations of plasma ir-inhibin were measured every 4 h during the periovulatory period. Inhibin pro-alphaC, a precursor protein of the inhibin alpha-subunit, was also measured. The changes in ir-inhibin and inhibin pro-alphaC in circulation were parallel. Concentrations of both ir-inhibin and inhibin pro-alphaC in the plasma increased at the same time when ovulatory follicles ruptured, and the peak levels of circulating ir-inhibin and inhibin pro-alphaC were maintained for 4-8 h. There was no selective increase in plasma concentrations of estradiol-17beta during the process of ovulation. These results suggest that the selective increase in ir-inhibin and inhibin pro-alphaC was caused by the absorption of follicular fluid after the rupture of ovulatory follicles. These results also suggest that the measuring of plasma concentrations of ir-inhibin or inhibin pro-alphaC in mares might be a useful method for detecting the time of ovulation.

UI MeSH Term Description Entries
D007265 Inhibins Glycoproteins that inhibit pituitary FOLLICLE STIMULATING HORMONE secretion. Inhibins are secreted by the Sertoli cells of the testes, the granulosa cells of the ovarian follicles, the placenta, and other tissues. Inhibins and ACTIVINS are modulators of FOLLICLE STIMULATING HORMONE secretions; both groups belong to the TGF-beta superfamily, as the TRANSFORMING GROWTH FACTOR BETA. Inhibins consist of a disulfide-linked heterodimer with a unique alpha linked to either a beta A or a beta B subunit to form inhibin A or inhibin B, respectively Female Inhibin,Inhibin,Inhibin-F,Inhibins, Female,Inhibins, Testicular,Ovarian Inhibin,Testicular Inhibin,Female Inhibins,Inhibin F,Inhibin, Female,Inhibin, Ovarian,Inhibin, Testicular,Testicular Inhibins
D007986 Luteinizing Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Luteinizing hormone regulates steroid production by the interstitial cells of the TESTIS and the OVARY. The preovulatory LUTEINIZING HORMONE surge in females induces OVULATION, and subsequent LUTEINIZATION of the follicle. LUTEINIZING HORMONE consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH and FSH), but the beta subunit is unique and confers its biological specificity. ICSH (Interstitial Cell Stimulating Hormone),Interstitial Cell-Stimulating Hormone,LH (Luteinizing Hormone),Lutropin,Luteoziman,Luteozyman,Hormone, Interstitial Cell-Stimulating,Hormone, Luteinizing,Interstitial Cell Stimulating Hormone
D010060 Ovulation The discharge of an OVUM from a rupturing follicle in the OVARY. Ovulations
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D011498 Protein Precursors Precursors, Protein
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D001947 Breeding The production of offspring by selective mating or HYBRIDIZATION, GENETIC in animals or plants. Breedings
D004797 Enzyme-Linked Immunosorbent Assay An immunoassay utilizing an antibody labeled with an enzyme marker such as horseradish peroxidase. While either the enzyme or the antibody is bound to an immunosorbent substrate, they both retain their biologic activity; the change in enzyme activity as a result of the enzyme-antibody-antigen reaction is proportional to the concentration of the antigen and can be measured spectrophotometrically or with the naked eye. Many variations of the method have been developed. ELISA,Assay, Enzyme-Linked Immunosorbent,Assays, Enzyme-Linked Immunosorbent,Enzyme Linked Immunosorbent Assay,Enzyme-Linked Immunosorbent Assays,Immunosorbent Assay, Enzyme-Linked,Immunosorbent Assays, Enzyme-Linked
D005260 Female Females
D005640 Follicle Stimulating Hormone A major gonadotropin secreted by the adenohypophysis (PITUITARY GLAND, ANTERIOR). Follicle-stimulating hormone stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and LEYDIG CELLS. FSH consists of two noncovalently linked subunits, alpha and beta. Within a species, the alpha subunit is common in the three pituitary glycoprotein hormones (TSH, LH, and FSH), but the beta subunit is unique and confers its biological specificity. FSH (Follicle Stimulating Hormone),Follicle-Stimulating Hormone,Follitropin

Related Publications

K Nagaoka, and Y Nambo, and N Nagamine, and S I Nagata, and Y Tanaka, and H Shinbo, and N Tsunoda, and H Taniyama, and G Watanabe, and N P Groome, and K Taya
January 2001, Archives of andrology,
K Nagaoka, and Y Nambo, and N Nagamine, and S I Nagata, and Y Tanaka, and H Shinbo, and N Tsunoda, and H Taniyama, and G Watanabe, and N P Groome, and K Taya
December 1999, Endocrinology,
K Nagaoka, and Y Nambo, and N Nagamine, and S I Nagata, and Y Tanaka, and H Shinbo, and N Tsunoda, and H Taniyama, and G Watanabe, and N P Groome, and K Taya
September 1999, The Journal of endocrinology,
K Nagaoka, and Y Nambo, and N Nagamine, and S I Nagata, and Y Tanaka, and H Shinbo, and N Tsunoda, and H Taniyama, and G Watanabe, and N P Groome, and K Taya
March 2002, Equine veterinary journal,
K Nagaoka, and Y Nambo, and N Nagamine, and S I Nagata, and Y Tanaka, and H Shinbo, and N Tsunoda, and H Taniyama, and G Watanabe, and N P Groome, and K Taya
September 2004, Fertility and sterility,
K Nagaoka, and Y Nambo, and N Nagamine, and S I Nagata, and Y Tanaka, and H Shinbo, and N Tsunoda, and H Taniyama, and G Watanabe, and N P Groome, and K Taya
April 2002, Fertility and sterility,
K Nagaoka, and Y Nambo, and N Nagamine, and S I Nagata, and Y Tanaka, and H Shinbo, and N Tsunoda, and H Taniyama, and G Watanabe, and N P Groome, and K Taya
December 1998, Human reproduction (Oxford, England),
K Nagaoka, and Y Nambo, and N Nagamine, and S I Nagata, and Y Tanaka, and H Shinbo, and N Tsunoda, and H Taniyama, and G Watanabe, and N P Groome, and K Taya
April 2003, Placenta,
K Nagaoka, and Y Nambo, and N Nagamine, and S I Nagata, and Y Tanaka, and H Shinbo, and N Tsunoda, and H Taniyama, and G Watanabe, and N P Groome, and K Taya
April 2002, Reproduction (Cambridge, England),
K Nagaoka, and Y Nambo, and N Nagamine, and S I Nagata, and Y Tanaka, and H Shinbo, and N Tsunoda, and H Taniyama, and G Watanabe, and N P Groome, and K Taya
October 2004, Endocrine,
Copied contents to your clipboard!